Olin
OLN
15.92
-0.29
-1.79%
Olin
US · OLN
#2848 by market cap
Listed 1970
15.92
-0.29
-1.79%
Live - 5344 symbols - heartbeat 467s ago
· 2026-10-08 08:15
Pre-market
15.71
-1.32%
After-hours
15.92
0.00%
Overnight
15.79
-0.82%
- Market cap
- 1.81B
- P/E (TTM)i
- -9.20
- P/Bi
- 1.06
- EPSi
- -0.88
- Div yieldi
- 5.03%
- 52W posi
- 6%
Reader sentiment
Are you bullish or bearish on OLN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.61, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.68% YoY
Margins
- Gross margin
- 7.40%
- Operating margin
- 0.57%
- Net margin
- -1.48%
Key ratios & quality
- Enterprise valuei
- 4.53B
- Altman Z-Scorei
- 1.61
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.95B | 6.11B | 5.76B | 8.91B | 9.38B | 6.83B | 6.54B | 6.78B |
| Gross profit | 1.12B | 670.80M | 383.40M | 2.29B | 2.18B | 1.17B | 737.50M | 501.50M |
| Selling & admin expenses | 430.60M | 416.90M | 422.00M | 416.90M | 393.90M | 406.70M | 408.50M | 463.30M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 693.80M | 254.30M | -37.90M | 1.88B | 1.80B | 801.70M | 329.80M | 38.70M |
| Pretax profit | 437.30M | -36.90M | -1.02B | 1.54B | 1.68B | 559.30M | 141.70M | -161.10M |
| Tax | 109.40M | -25.60M | -50.10M | 242.00M | 349.10M | 107.30M | 36.70M | -60.00M |
| Net profit | 327.90M | -11.30M | -969.90M | 1.30B | 1.33B | 452.00M | 105.00M | -101.10M |
| Basic EPS | 2 | 0 | -6 | 8 | 9 | 4 | 1 | -1 |
| Diluted EPS | 1.95 | -0.07 | -6.14 | 7.96 | 8.94 | 3.57 | 0.91 | -0.88 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.64B | 1.76B | 1.71B | 1.67B | 1.58B | 1.74B |
| Gross profit | 148.70M | 138.10M | 183.40M | 31.30M | 75.80M | 170.20M |
| Selling & admin expenses | 101.00M | 95.20M | 98.10M | 169.00M | 145.00M | 102.70M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 47.70M | 42.70M | 85.70M | -137.40M | -69.20M | 67.60M |
| Pretax profit | 2.10M | -6.80M | 41.50M | -197.90M | -118.30M | 3.80M |
| Tax | 900.00K | -4.00M | -2.20M | -54.70M | -35.30M | 17.10M |
| Net profit | 1.20M | -2.80M | 43.70M | -143.20M | -83.00M | -13.30M |
| Basic EPS | 0 | 0 | 0 | -1 | -1 | 0 |
| Diluted EPS | 0.01 | -0.01 | 0.37 | -0.75 | -0.73 | -0.12 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.71B | 1.71B | 1.72B | 2.25B | 2.16B | 1.97B | 2.08B | 1.97B |
| Cash & ST investments | 178.80M | 220.90M | 189.70M | 180.50M | 194.00M | 170.30M | 175.60M | 167.60M |
| Inventory | 711.40M | 695.70M | 674.70M | 868.30M | 941.90M | 858.80M | 823.50M | 784.50M |
| Total assets | 9.00B | 9.19B | 8.27B | 8.52B | 8.04B | 7.71B | 7.58B | 7.33B |
| Total current liabilities | 1.12B | 1.08B | 1.20B | 1.68B | 1.56B | 1.53B | 1.63B | 1.63B |
| Short-term debt | 125.90M | 81.40M | 101.00M | 277.90M | 81.50M | 148.10M | 193.80M | 169.40M |
| Long-term debt | 3.10B | 3.34B | 3.84B | 2.58B | 2.57B | 2.59B | 2.71B | 2.72B |
| Total liabilities | 6,165,200,000.00 | 6,770,300,000.00 | 6,820,100,000.00 | 5,865,500,000.00 | 5,500,600,000.00 | 5,444,900,000.00 | 5,523,700,000.00 | 5,455,200,000.00 |
| Total equity | 2.83B | 2.42B | 1.45B | 2.65B | 2.54B | 2.27B | 2.06B | 1.87B |
| Retained earnings | 1.07B | 941.10M | -155.10M | 1.01B | 2.22B | 2.58B | 2.36B | 2.14B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.25B | 2.29B | 2.26B | 1.97B | 2.10B | 2.19B |
| Cash & ST investments | 174.00M | 223.80M | 140.30M | 167.60M | 192.20M | 177.40M |
| Inventory | 875.20M | 919.10M | 966.90M | 784.50M | 827.20M | 847.20M |
| Total assets | 7.66B | 7.67B | 7.60B | 7.33B | 7.35B | 7.44B |
| Total current liabilities | 1.44B | 1.55B | 1.45B | 1.63B | 1.54B | 1.54B |
| Short-term debt | 81.70M | 80.20M | 79.80M | 169.40M | 60.50M | 73.00M |
| Long-term debt | 3.02B | 2.98B | 2.97B | 2.72B | 3.00B | 3.03B |
| Total liabilities | 5,616,900,000.00 | 5,680,100,000.00 | 5,607,200,000.00 | 5,455,200,000.00 | 5,619,100,000.00 | 5,728,800,000.00 |
| Total equity | 2.04B | 1.99B | 1.99B | 1.87B | 1.73B | 1.71B |
| Retained earnings | 2.32B | 2.29B | 2.31B | 2.14B | 2.03B | 2.00B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 907.80M | 617.30M | 433.00M | 1.74B | 1.92B | 974.30M | 503.20M | 474.20M |
| Depreciation & amortization | 601.40M | 597.40M | 568.40M | 582.50M | 598.80M | 533.40M | 518.10M | 521.60M |
| Free cash flow | 522.60M | 231.70M | 134.10M | 1.54B | 1.69B | 738.30M | 308.10M | 247.90M |
| Dividends paid | -133.60M | -129.30M | -126.30M | -127.80M | -116.20M | -101.00M | -94.20M | -91.60M |
| Stock buybacks / issuance | -50.00M | -145.90M | 0 | -251.90M | -1.35B | -711.30M | -300.30M | -50.50M |
| Ending cash balance | 178.80M | 220.90M | 189.70M | 180.50M | 194.00M | 170.30M | 175.60M | 167.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -86.00M | 212.30M | 26.70M | 321.20M | -48.60M | 7.90M |
| Depreciation & amortization | 132.20M | 129.90M | 133.80M | 125.70M | 117.20M | 122.10M |
| Free cash flow | -147.40M | 181.30M | -44.40M | 258.40M | -92.30M | -21.10M |
| Dividends paid | -23.00M | -23.00M | -22.80M | -22.80M | -22.80M | -22.80M |
| Stock buybacks / issuance | -20.20M | -10.10M | -10.10M | -10.10M | 0 | 0 |
| Ending cash balance | 174.00M | 223.80M | 140.30M | 167.60M | 192.20M | 177.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.74 | -0.43 | -50.15 | 63.21 | 51.08 | 19.27 | 5.10 | -5.20 |
| ROA %i | 3.60 | -0.12 | -11.11 | 15.45 | 16.02 | 5.84 | 1.42 | -1.35 |
| ROIC %i | 8.19 | 2.71 | -11.71 | 27.67 | 25.47 | 11.23 | 4.65 | 0.30 |
| 5-year avg ROE %i | 8.67 | 6.59 | -3.43 | 9.25 | 15.09 | 16.60 | 17.70 | 26.69 |
| EBIT margin %i | 9.80 | 3.38 | -12.63 | 21.17 | 19.41 | 10.84 | 4.99 | 0.40 |
| FCF / sales %i | 7.52 | 3.79 | 2.08 | 17.29 | 17.97 | 10.80 | 4.71 | 3.66 |
| Current ratioi | 1.53 | 1.58 | 1.43 | 1.34 | 1.38 | 1.29 | 1.27 | 1.21 |
| Quick ratioi | 0.86 | 0.92 | 0.81 | 0.77 | 0.74 | 0.69 | 0.73 | 0.66 |
| Debt / assetsi | 35.90 | 40.53 | 51.14 | 37.08 | 36.61 | 39.19 | 41.56 | 42.86 |
| LT debt / equityi | 109.61 | 150.66 | 284.61 | 108.60 | 112.58 | 128.76 | 146.13 | 161.52 |
| Interest coveragei | 2.80 | 0.85 | -2.48 | 5.42 | 12.65 | 4.09 | 1.77 | 0.14 |
| Revenue CAGR (3Y) %i | 34.51 | 3.25 | -2.79 | 8.66 | 15.34 | 5.87 | -9.80 | -10.24 |
| Net income CAGR (3Y) %i | -- | -- | -- | 58.14 | -- | -- | -56.25 | -- |
| FCF CAGR (3Y) %i | 82.34 | -10.68 | -27.68 | 43.38 | 93.74 | 76.58 | -41.52 | -47.21 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 2.97 | -0.69 | 2.67 | -5.20 | -9.88 | -10.73 |
| ROA %i | 0.81 | -0.18 | 0.71 | -1.35 | -2.46 | -2.61 |
| ROIC %i | 3.60 | 2.65 | 3.75 | 0.30 | -1.29 | -1.26 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.15 | 2.53 | 3.44 | 0.40 | -1.47 | -1.33 |
| FCF / sales %i | 1.89 | 4.07 | 1.18 | 3.66 | 4.51 | 1.50 |
| Current ratioi | 1.56 | 1.48 | 1.56 | 1.21 | 1.36 | 1.42 |
| Quick ratioi | 0.90 | 0.84 | 0.84 | 0.66 | 0.76 | 0.79 |
| Debt / assetsi | 43.50 | 42.83 | 43.47 | 42.86 | 45.02 | 45.80 |
| LT debt / equityi | 161.94 | 163.70 | 164.33 | 161.52 | 187.42 | 194.84 |
| Interest coveragei | 1.44 | 0.89 | 1.25 | 0.14 | -0.54 | -0.49 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Chlor Alkali Products and Vinyls is the largest reported line at 47.05% of revenue, across 3 reported segments.
- Winchester follows at 28.72%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Chlor Alkali Products and Vinyls47.05%
Winchester28.72%
Epoxy24.23%
Quote time 2026-10-08 08:15:25 · For reference only, not investment advice and not tailored to your situation.